Abnormal MGMT Promoter Methylation in Gastrointestinal Stromal Tumors: Genetic Susceptibility and Association with Clinical Outcome
Liping Lou,1,* Wendi Zhang,2,* Jun Li,1 Yu Wang1 1Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China; 2Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Sc...
Main Authors: | Lou L, Zhang W, Li J, Wang Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/abnormal-mgmt-promoter-methylation-in-gastrointestinal-stromal-tumors--peer-reviewed-article-CMAR |
Similar Items
-
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents
by: Riccardo Ricci, et al.
Published: (2019-01-01) -
Quantitative Analysis of the <i>MGMT</i> Methylation Status of Glioblastomas in Light of the 2021 WHO Classification
by: Levin Häni, et al.
Published: (2022-06-01) -
Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo
by: Thomas C. Chen, et al.
Published: (2018-09-01) -
Research and application progress of MGMT promoter methylation in gliomas
by: Cui-yun SUN, et al.
Published: (2014-07-01) -
Determining methylation status of methylguanine DNA methyl transferase (MGMT) from formalin-fixed, paraffin embedded tumor tissue
by: Francine B. de Abreu, et al.
Published: (2014-01-01)